Brief: Clover Biopharmaceuticals Says Unit Entered Into Long-Term Agreement With UNICEF

Clover Biopharmaceuticals

07/12/2021 13:13

Dec 7 (Reuters) - Clover Biopharmaceuticals Ltd  2197.HK :
    * UNIT ENTERED INTO LONG-TERM AGREEMENT WITH UNICEF TO
SUPPLY UP
TO 414 MILLION DOSES OF CO'S COVID-19 VACCINE CANDIDATE
    * DEAL TO SUPPLY DOSES OF COVID-19 VACCINE THROUGH END OF
2022
    * DEAL WILL ALLOW PARTICIPATING COUNTRIES OF COVAX FACILITY
TO
ACCESS CO'S VACCINE

Further company coverage:  2197.HK 

 ((Reuters.Briefs@thomsonreuters.com;))